Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6988 results

Sort By:

Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor

Study ID: NCT04690374
Start Date: 2020-12-22
End Date: 2027-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

250

Intervention / Treatment
Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid Tumors

Study ID: NCT06914128
Start Date: 2025-03-21
End Date: 2029-06-17
Study Type

Interventional

Study Phase

Phase2

No. of Participants

370

Intervention / Treatment

BAY 3713372

Sponsor

Bayer

Source: clinicaltrials.gov

Share:
Add to list

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population

Study ID: NCT06997068
Start Date: 2025-07-09
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

25

Intervention / Treatment

Celecoxib

Erlotinib Hydrochloride

Imaging Procedure

Interview

Methotrexate

Administration Questionnaire

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies

Study ID: NCT03089554
Start Date: 2017-04-11
End Date: 2026-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

93

Intervention / Treatment

Therapeutic Intervention

Sponsor

Rachel Miller

Source: clinicaltrials.gov

Share:
Add to list

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

Study ID: NCT04486352
Start Date: 2021-10-20
End Date: 2027-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

148

Intervention / Treatment

Atezolizumab - 28 Day Cycle

bevacizumab

Ipatasertib

Talazoparib

Trastuzumab emtansine

Tiragolumab

Atezolizumab - 21 Day Cycle

Involisib

Letrozole

Giredestrant

Abemaciclib

Sponsor

Alliance Foundation Trials, LLC.

Source: clinicaltrials.gov

Share:
Add to list

SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)

Study ID: NCT06945315
Start Date: 2023-11-14
End Date: 2027-07-14
Study Type

Interventional

Study Phase

Phase3

No. of Participants

196

Intervention / Treatment

RALP (Robotic-assisted radical prostatectomy)

SAFE (Saline assisted fascial engorgement)

Sponsor

Icahn School of Medicine at Mount Sinai

Source: clinicaltrials.gov

Share:
Add to list

Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies

Study ID: NCT03458676
Start Date: 2012-09-06
End Date: 2025-11-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

62

Intervention / Treatment

Advanced Magnetic Resonance Imaging Scan

Standard of Care Brain Biopsy and Tumor Removal

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Pilot Trial of Spiritual Care Interventions for Patients With Cancer

Study ID: NCT06811376
Start Date: 2025-02-13
End Date: 2027-04-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

64

Intervention / Treatment

Spiritual Care Intervention #1

Spiritual Care Intervention #2

Sponsor

Weill Medical College of Cornell University

Source: clinicaltrials.gov

Share:
Add to list

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

Study ID: NCT03374215
Start Date: 2017-12-14
End Date: 2025-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1150

Intervention / Treatment
Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Source: clinicaltrials.gov

Share:
Add to list

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Study ID: NCT04302025
Start Date: 2020-11-06
End Date: 2030-05-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

99

Intervention / Treatment

Alectinib

Entrectinib

Vemurafenib

Cobimetinib

Pralcetinib

Atezolizumab

SBRT

Resection

Chemotherapy

The wall

Sponsor

Genentech, Inc.

Source: clinicaltrials.gov

Share:
Add to list